To determine which function of VPS34 drives dependency in cancer cells, we carried out a series of studies using PIK-III, a potent and selective inhibitor of VPS34 [1] to control the degree and timing of VPS34 inhibition. This evidence concerns the gene PIK3C3 and cancer.